David Caponera

Executive Director, Patient Advocacy, Communication, Public Affairs, and Sustainability at Novo Nordisk

Speaker

David Caponera, Executive Director, Patient Advocacy, Novo Nordisk

A patient focused leader who has the privilege to bridge the patient perspective and company goals to support the dynamics in today’s healthcare arena by being the Patient Advocacy liaison with extensive rare disorders experience in which specialty / orphan products are being developed and implemented. A Registered Respiratory Therapist who has worked clinically and then moved into the world of Managed Care, Specialty Pharmacy, and landing in biotechnology with a focus on ultra-rare disorders having experience at Genzyme, Amicus Therapeutics, Pfizer, Aegerion, Catalyst Pharmaceuticals, and Dicerna Pharmaceuticals.